taurocholic acid has been researched along with Recrudescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brito-Silva, C; Castro-Córdova, P; Cofré-Araneda, G; Kuehne, SA; Mendoza-León, MJ; Minton, NP; Mora-Uribe, P; Orozco-Aguilar, J; Paredes-Sabja, D; Pizarro-Guajardo, M; Reyes-Ramírez, R | 1 |
| Kyne, L; Martin, A; Moore, P; Solomon, K | 1 |
2 other study(ies) available for taurocholic acid and Recrudescence
| Article | Year |
|---|---|
Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection.
Topics: Animals; Bacterial Adhesion; Bacterial Proteins; Cell Line; Clostridioides difficile; Clostridium Infections; Collagen; Endocytosis; Epithelial Cells; Female; Fibronectins; Humans; Integrins; Intestinal Mucosa; Intestines; Male; Mice, Inbred C57BL; Nystatin; Protein Binding; Recurrence; Spores, Bacterial; Taurocholic Acid; Vitronectin | 2021 |
Germination efficiency of clinical Clostridium difficile spores and correlation with ribotype, disease severity and therapy failure.
Topics: Clostridioides difficile; Clostridium Infections; Culture Media; Humans; Recurrence; Ribotyping; Severity of Illness Index; Species Specificity; Spores, Bacterial; Taurocholic Acid; Treatment Failure | 2013 |